{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:22:58Z","timestamp":1789611778740,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["psychiatricnursing.org","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Psychiatric Nursing"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.apnu.2024.09.008","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T06:12:31Z","timestamp":1727935951000},"page":"62-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of sociodemographic factors and depression on medication adherence in schizophrenia: Cross sectional study in Morocco"],"prefix":"10.1016","volume":"53","author":[{"given":"Jalal","family":"Doufik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Lahlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"El Oumary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zineb","family":"Salehddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amine","family":"Tbatou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"El Abbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouad","family":"Laboudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Mouhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Rammouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.apnu.2024.09.008_bb0005","first-page":"273","article-title":"Facteurs de risque de l\u2019inobservance th\u00e9rapeutique chez les patients schizophr\u00e8nes: \u00e9tude cas-t\u00e9moins [Risk factors for treatment adherence in patients with schizophrenia: case-control study]","volume":"Mar 20","author":"Aarab","year":"2015","journal-title":"The Pan African Medical Journal"},{"issue":"2\u20133","key":"10.1016\/j.apnu.2024.09.008_bb0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.schres.2008.09.007","article-title":"Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS) and its relationship to sociodemographic, clinical and psychopathological variables","volume":"107","author":"Acosta","year":"2009","journal-title":"Schizophrenia Research"},{"issue":"2\u20133","key":"10.1016\/j.apnu.2024.09.008_bb0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0920-9964(95)00070-4","article-title":"A psychometric comparison of the Calgary depression scale for schizophrenia and the Hamilton depression rating scale","volume":"19","author":"Addington","year":"1996","journal-title":"Schizophrenia Research"},{"issue":"3","key":"10.1016\/j.apnu.2024.09.008_bb0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0920-9964(94)90017-5","article-title":"Specificity of the Calgary depression scale for schizophrenics","volume":"11","author":"Addington","year":"1994","journal-title":"Schizophrenia Research"},{"issue":"4","key":"10.1016\/j.apnu.2024.09.008_bb0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0920-9964(90)90005-R","article-title":"A depression rating scale for schizophrenics","volume":"3","author":"Addington","year":"1990","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.apnu.2024.09.008_bb0030","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"issue":"1","key":"10.1016\/j.apnu.2024.09.008_bb0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.psychres.2010.06.013","article-title":"Novelty seeking and medication adherence in patients with schizophrenia","volume":"186","author":"Aukst Margeti\u0107","year":"2011","journal-title":"Psychiatry Research"},{"issue":"1","key":"10.1016\/j.apnu.2024.09.008_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.eurpsy.2011.02.005","article-title":"Interventions to improve adherence to antipsychotic medication in patients with schizophrenia\u2013A review of the past decade","volume":"27","author":"Barkhof","year":"2012","journal-title":"European Psychiatry"},{"key":"10.1016\/j.apnu.2024.09.008_bb0045","first-page":"43","article-title":"Organizational research: Determining appropriate sample size in survey research","volume":"19","author":"Barlett","year":"2001","journal-title":"Information Technology, Learning, and Performance Journal"},{"key":"10.1016\/j.apnu.2024.09.008_bb0050","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1192\/bjp.195.52.s37","article-title":"Antipsychotic long-acting injections: Prescribing practice in the UK","volume":"52","author":"Barnes","year":"2009","journal-title":"The British Journal of Psychiatry. Supplement"},{"issue":"1","key":"10.1016\/j.apnu.2024.09.008_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.apnu.2016.09.003","article-title":"Measuring medication adherence in patients with schizophrenia: An integrative review","volume":"31","author":"Bright","year":"2016","journal-title":"Archives of Psychiatric Nursing"},{"issue":"4","key":"10.1016\/j.apnu.2024.09.008_bb0060","first-page":"304","article-title":"Medication adherence: WHO cares?","volume":"86","author":"Brown","year":"2011"},{"key":"10.1016\/j.apnu.2024.09.008_bb0065","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.schres.2021.04.002","article-title":"The alliance-outcome relationship in individual psychosocial treatment for schizophrenia and early psychosis: A meta-analysis","volume":"231","author":"Browne","year":"2021","journal-title":"Schizophrenia Research"},{"issue":"3","key":"10.1016\/j.apnu.2024.09.008_bb0070","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.psc.2007.04.002","article-title":"Antipsychotic medication adherence in schizophrenia","volume":"30","author":"Byerly","year":"2007","journal-title":"The Psychiatric Clinics of North America"},{"key":"10.1016\/j.apnu.2024.09.008_bb0075","series-title":"Sampling techniques","author":"Cochran","year":"1977"},{"issue":"1\u20133","key":"10.1016\/j.apnu.2024.09.008_bb0080","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.schres.2006.09.027","article-title":"The burden of depressive symptoms in the long-term treatment of patients with schizophrenia","volume":"90","author":"Conley","year":"2007","journal-title":"Schizophrenia Research"},{"issue":"2","key":"10.1016\/j.apnu.2024.09.008_bb0085","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1192\/bjp.bp.109.073429","article-title":"The Kraepelinian dichotomy - Going, going... but still not gone","volume":"196","author":"Craddock","year":"2010","journal-title":"The British Journal of Psychiatry"},{"issue":"14","key":"10.1016\/j.apnu.2024.09.008_bb0090","article-title":"Antipsychotic treatment failure: A systematic review on risk factors and interventions for treatment adherence in psychosis","volume":"Oct 9","author":"El Abdellati","year":"2020","journal-title":"Frontiers in Neuroscience"},{"issue":"6","key":"10.1016\/j.apnu.2024.09.008_bb0095","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.encep.2016.02.022","article-title":"\u00c9tude de l\u2019observance th\u00e9rapeutique chez une population de patients atteints de schizophr\u00e9nie au Maroc [predictors of medication non-adherence among a Moroccan sample of patients with schizophrenia: A cross sectional study]","volume":"43","author":"El Ammouri","year":"2017","journal-title":"Encephale"},{"issue":"10","key":"10.1016\/j.apnu.2024.09.008_bb0100","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/01.nmd.0000180742.51075.70","article-title":"Medication nonadherence and substance abuse in psychotic disorders: Impact of depressive symptoms and social stability","volume":"193","author":"Elbogen","year":"2005","journal-title":"The Journal of Nervous and Mental Disease"},{"issue":"7","key":"10.1016\/j.apnu.2024.09.008_bb0105","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1176\/appi.ps.52.7.911","article-title":"Diagnosis and treatment of mood disorders that co-occur with schizophrenia","volume":"52","author":"Escamilla","year":"2001","journal-title":"Psychiatric Services"},{"issue":"3","key":"10.1016\/j.apnu.2024.09.008_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120560","article-title":"Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia","volume":"Mar 27;10","author":"Eticha","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.apnu.2024.09.008_bb0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00001504-200101000-00004","article-title":"Comorbid conditions in schizophrenia","volume":"14","author":"Fenton","year":"2001","journal-title":"Current Opinion in Psychiatry"},{"issue":"4","key":"10.1016\/j.apnu.2024.09.008_bb0120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/JCP.0000000000000523","article-title":"Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients: A systematic review","volume":"36","author":"Garc\u00eda","year":"2016","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.apnu.2024.09.008_bb0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.schres.2016.02.034","article-title":"Subjective quality of life in first-episode psychosis. A ten year follow-up study","volume":"172","author":"Gardsjord","year":"2016","journal-title":"Schizophrenia Research"},{"issue":"4","key":"10.1016\/j.apnu.2024.09.008_bb0130","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1176\/appi.ajp.161.4.692","article-title":"Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia","volume":"161","author":"Gilmer","year":"2004","journal-title":"The American Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.apnu.2024.09.008_bb0135","first-page":"127","article-title":"Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder","volume":"21","author":"Greene","year":"2018"},{"issue":"1","key":"10.1016\/j.apnu.2024.09.008_bb0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41537-023-00356-x","article-title":"Influencing factors of medication adherence in schizophrenic patients: A meta-analysis","volume":"9","author":"Guo","year":"2023","journal-title":"Schizophrenia (Heidelb)"},{"key":"10.1016\/j.apnu.2024.09.008_bb0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/PROM.S42735","article-title":"Nonadherence with antipsychotic medication in schizophrenia: Challenges and management strategies","volume":"5","author":"Haddad","year":"2014","journal-title":"Patient Related Outcome Measures"},{"issue":"9","key":"10.1016\/j.apnu.2024.09.008_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162304","article-title":"Validation of the Arabic version of Calgary depression scale for schizophrenia","volume":"Sep 1;11","author":"Hani","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.apnu.2024.09.008_bb0155","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jpsychires.2021.05.038","article-title":"Interrelationships between depressive symptoms and positive and negative symptoms of recent onset schizophrenia spectrum disorders: A network analytical approach","volume":"140","author":"Herniman","year":"2021","journal-title":"Journal of Psychiatric Research"},{"issue":"4","key":"10.1016\/j.apnu.2024.09.008_bb0160","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/2045125312474019","article-title":"Medication adherence in schizophrenia: Factors influencing adherence and consequences of nonadherence, a systematic literature review","volume":"3","author":"Higashi","year":"2013","journal-title":"Therapeutic Advances in Psychopharmacology"},{"issue":"2","key":"10.1016\/j.apnu.2024.09.008_bb0165","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4088\/JCP.v65n0211","article-title":"A pilot study of barriers to medication adherence in schizophrenia","volume":"65","author":"Hudson","year":"2004","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.apnu.2024.09.008_bb0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40273-016-0444-6","article-title":"The societal cost of schizophrenia: A systematic review","volume":"35","author":"Jin","year":"2017","journal-title":"Pharmacoeconomics"},{"issue":"11","key":"10.1016\/j.apnu.2024.09.008_bb0175","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1080\/03007995.2016.1219706","article-title":"Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: Risperidone versus paliperidone palmitate","volume":"32","author":"Joshi","year":"2016","journal-title":"Current Medical Research and Opinion"},{"issue":"1","key":"10.1016\/j.apnu.2024.09.008_bb0180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4088\/JCP.v68n0110","article-title":"Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia","volume":"68","author":"Karow","year":"2007","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.apnu.2024.09.008_bb0185","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/560836","article-title":"Long-acting injectable antipsychotics for first-episode schizophrenia: The pros and cons","volume":"2012","author":"Kim","year":"2012","journal-title":"Schizophrenia Research and Treatment"},{"issue":"10","key":"10.1016\/j.apnu.2024.09.008_bb0190","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4088\/JCP.v63n1007","article-title":"Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature","volume":"63","author":"Lacro","year":"2002","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.apnu.2024.09.008_bb0195","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-0327(99)00075-0","article-title":"Study of the concurrent validity of the Calgary depression scale for schizophrenics (CDSS)","volume":"58","author":"Lan\u00e7on","year":"2000","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.apnu.2024.09.008_bb0200","article-title":"Adherence and persistence to long-acting injectable dopamine receptor blocking agent therapy in the United States: A systematic review and meta-analysis of cohort studies","volume":"Dec;306","author":"Lee","year":"2021","journal-title":"Psychiatry Research"},{"issue":"4","key":"10.1016\/j.apnu.2024.09.008_bb0205","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/oxfordjournals.schbul.a006898","article-title":"A prospective study of factors influencing adherence to a continuous neuroleptic treatment program in schizophrenia patients during 2 years","volume":"27","author":"Linden","year":"2001","journal-title":"Schizophrenia Bulletin"},{"issue":"7","key":"10.1016\/j.apnu.2024.09.008_bb0210","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4088\/JCP.08m04221","article-title":"Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response","volume":"70","author":"Lindenmayer","year":"2009","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1016\/j.apnu.2024.09.008_bb0215","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-2003-39985","article-title":"Schizophrenic patients\u2019 subjective reasons for compliance and noncompliance with neuroleptic treatment","volume":"36","author":"L\u00f6ffler","year":"2003","journal-title":"Pharmacopsychiatry"},{"issue":"7","key":"10.1016\/j.apnu.2024.09.008_bb0220","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4088\/JCP.08m04408","article-title":"Treatment nonadherence and neurocognitive impairment in bipolar disorder","volume":"70","author":"Martinez-Aran","year":"2009","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.apnu.2024.09.008_bb0225","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.schres.2009.04.018","article-title":"A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia","volume":"113","author":"Miller","year":"2009","journal-title":"Schizophrenia Research"},{"issue":"9","key":"10.1016\/j.apnu.2024.09.008_bb0230","doi-asserted-by":"crossref","first-page":"e1130","DOI":"10.4088\/JCP.15m10115","article-title":"Determination of adherence profiles in schizophrenia using self-reported adherence: Results from the FACE-SZ dataset","volume":"77","author":"Misdrahi","year":"2016","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1016\/j.apnu.2024.09.008_bb0235","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.4088\/JCP.v65n0908","article-title":"Compliance in schizophrenia: Psychopathology, side effects, and patients\u2019 attitudes toward the illness and medication","volume":"65","author":"Rettenbacher","year":"2004","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.apnu.2024.09.008_bb0240","series-title":"Poor adherence to antipsychotic medication in people with schizophrenia: Diffusion, consequences and contributing factors (Sacchetti E, Vita A, Siracusano A, Fleischhacker WW, eds)","first-page":"1","author":"Sacchetti","year":"2014"},{"issue":"1","key":"10.1016\/j.apnu.2024.09.008_bb0245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13643-020-1274-3","article-title":"Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: A systematic review and meta-analysis","volume":"9","author":"Semahegn","year":"2020","journal-title":"Systematic Reviews"},{"issue":"2\u20133","key":"10.1016\/j.apnu.2024.09.008_bb0250","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0920-9964(00)00135-3","article-title":"Depression in schizophrenia: Recognition and management in the USA","volume":"47","author":"Siris","year":"2001","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1016\/j.apnu.2024.09.008_bb0255","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/157488412799218761","article-title":"Antipsychotic medication adherence and satisfaction among Palestinian people with schizophrenia","volume":"7","author":"Sweileh","year":"2012","journal-title":"Current Clinical Pharmacology"},{"issue":"6","key":"10.1016\/j.apnu.2024.09.008_bb0260","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.apnu.2016.07.007","article-title":"Factors affecting medication adherence among adults with schizophrenia: A literature review","volume":"30","author":"Tham","year":"2016","journal-title":"Archives of Psychiatric Nursing"},{"issue":"3","key":"10.1016\/j.apnu.2024.09.008_bb0265","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0920-9964(99)00130-9","article-title":"Reliability and validity of a new medication adherence rating scale (MARS) for the psychoses","volume":"42","author":"Thompson","year":"2000","journal-title":"Schizophrenia Research"},{"issue":"3","key":"10.1016\/j.apnu.2024.09.008_bb0270","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1600-0447.2009.01506.x","article-title":"The evolution of depression and suicidality in first episode psychosis","volume":"122","author":"Upthegrove","year":"2010","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"2","key":"10.1016\/j.apnu.2024.09.008_bb0275","first-page":"240","article-title":"Depression and schizophrenia: Cause, consequence, or trans-diagnostic issue?","volume":"43","author":"Upthegrove","year":"2017","journal-title":"Schizophrenia Bulletin"},{"issue":"7","key":"10.1016\/j.apnu.2024.09.008_bb0280","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-0030-1263172","article-title":"Effect of early dysphoric response and cannabis use on discontinuation of olanzapine or risperidone in patients with early psychosis","volume":"43","author":"van Nimwegen-Campailla","year":"2010","journal-title":"Pharmacopsychiatry"},{"issue":"9","key":"10.1016\/j.apnu.2024.09.008_bb0285","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1176\/ps.2007.58.9.1187","article-title":"Relationships among subjective and objective measures of adherence to oral antipsychotic medications","volume":"58","author":"Velligan","year":"2007","journal-title":"Psychiatric Services"},{"issue":"1","key":"10.1016\/j.apnu.2024.09.008_bb0290","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.pra.0000367776.96012.ca","article-title":"Assessment of adherence problems in patients with serious and persistent mental illness: Recommendations from the expert consensus guidelines","volume":"16","author":"Velligan","year":"2010","journal-title":"Journal of Psychiatric Practice"},{"issue":"Suppl. 4","key":"10.1016\/j.apnu.2024.09.008_bb0295","first-page":"1","article-title":"The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness","volume":"70","author":"Velligan","year":"2009","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1016\/j.apnu.2024.09.008_bb0300","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/schbul\/21.3.419","article-title":"Cost of relapse in schizophrenia","volume":"21","author":"Weiden","year":"1995","journal-title":"Schizophrenia Bulletin"},{"issue":"3","key":"10.1016\/j.apnu.2024.09.008_bb0305","first-page":"269","article-title":"Autonomous regulation and long-term medication adherence in adult outpatients","volume":"17","author":"Williams","year":"1998"},{"issue":"1\u20133","key":"10.1016\/j.apnu.2024.09.008_bb0310","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.schres.2006.11.026","article-title":"Association between psychotic experiences and depression in a clinical sample over 6 months","volume":"91","author":"Yung","year":"2007","journal-title":"Schizophrenia Research"}],"container-title":["Archives of Psychiatric Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883941724001882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883941724001882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T16:04:19Z","timestamp":1737734659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883941724001882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":62,"alternative-id":["S0883941724001882"],"URL":"https:\/\/doi.org\/10.1016\/j.apnu.2024.09.008","relation":{},"ISSN":["0883-9417"],"issn-type":[{"value":"0883-9417","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of sociodemographic factors and depression on medication adherence in schizophrenia: Cross sectional study in Morocco","name":"articletitle","label":"Article Title"},{"value":"Archives of Psychiatric Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apnu.2024.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}